INTRODUCTION
Arthritis in children often presents with manifestations that would be considered unusual in adults such as daily high fever, hepatosplenomegaly, and rash. Yet juvenile rheumatoid arthritis (JRA),1 like lupus, polymyositis, or scleroderma with onset in childhood, has commonly been considered to be essentially the same disease as seen in the adult but modified by the younger age of the host. In recent years pediatric rheumatologists have attempted to classify JRA into several distinct onset syndromes (1) . These subdivisions are based on the number of affected joints, pauciarticular or poly-articular, and on the presence or absence of daily intermittent fever, which defines the systemic form. Certain children with chronic arthritis may develop a clinical syndrome with spine and sacroilliac involvement similar to ankylosing spondylitis (2) .
In previous publications from this laboratory (3) it has been reported that HLA-DW4, and the associated Ia-like antigen DRW4, are strongly associated with rheumatoid arthritis (RA) in Caucasian adult patients. The relative risk for development of RA was six times greater in HLA-DW4-positive individuals than in those who lacked the antigen (3). These results suggested that immunogenetic factors were involved in the development of RA of adult onset.
We have now investigated 126 Caucasian patients with JRA who were tested for HLA-A, B, and D antigens. The results are surprisingly different from what was found in adults. In children who met the criteria for JRA (1) the frequency of HLA-DW4 was lower than in controls whereas other antigens of the HLA-D locus were increased. The persistent pauciarticular group appeared to have a strong association with a new HLA-D determinant that was characterized with a typing cell from a child with JRA. This new antigen will be described.
METHODS
The 126 patients with JRA, entered at random in this study, were attending the pediatric rheumatology clinic, Texas Scottish Rite Hospital for Crippled Children, or were hospitalized at the Children's Medical Center, Dallas, Tex. They were under the care of one of us (C. W. Fink) and were classified on the basis of clinical criteria without knowledge of the HLAtyping results.
Criteria used for classification of patients were adapted from those previously published by the JRA Criteria Subcommittee (1) . 67 patients had a pauciarticular onset, in 31 the onset was polyarticular, and in 28 it was systemic. The pauciarticular group was further subdivided into four subsets. Of the 67 patients with pauciarticular onset, 12 had had a chronic iritis and 10 were boys whose illness began after the age of 9 yr. Of the remaining 45 patients, 26 had a persistent pauciarticular course and 19 converted to a polyarticular form of the disease by later having a total of more than four involved joints (Table I) . Typing for the HLA-D locus determinants was performed by mixed lymphocyte culture with a microtiter procedure as previously described (4) . Each reaction mixture contained 105 frozen and thawed responding lymphocytes and a similar number of frozen and thawed stimulating lymphocytes which had been previously irradiated (3, (Table III) .
In Table IV , the patients have been divided into the three major clinical groups according to mode of onset. The lowest frequency of DW4 was observed in the pauciarticular group in which the elevations in DW7, DW8, and TMo were found.
The antigen HLA-DW7 was also found more frequently in patients with a systemic onset. This result however, is based on typing of only 14 patients and must be investigated further.
TMo, an HLA-D specificity that belongs to the DW7-DW1I cross-reactive group. TMo was discovered in random checkerboard cultures with cells from patients with JRA. TMo lymphocytes typed HLA-A2, AW26, BW15, BW37. The family checker- Table VI , it can be seen that the strongest association was with the persistent pauciarticular group (group A3). The results indicate that a child having the antigen TMo has a 68-fold greater chance of developing this form of arthritis. Thus it would appear that the association between TMo and JRA with a pauciarticular onset, is largely a result of patients with the persistent pauciarticular form of the disease. In groups Al (with iritis), B (polyarticular onset), and C (systemic onset), the relative risks were not significantly different from unity. that of DRW4 (11) in RA have been confirmed by other investigators. It was therefore surprising to find that children with RA only rarely had these antigens. In the present study, involving 126 JRA patients, the fre-(uency of DW4 was not only significantly lower than in adult RA but was even significantly lowver than in the Caucasian normal controls. HLA-DRW4, teste(l by cytotoxicity on isolated B cells, was also not increased in children with RA. Moreover, none of the clinically identified subgroups of JRA showed an increase in DW4. We then investigated a group of children with polyarthritis, rheumatoid f:actor, and sul)cutaneous nodules whose disease most closely resemiibles adult RA. Only eight such patients were available btut, evi-(lently, also in this group HLA-DW4/DRW4 was niot increased because only one out of the eight was positive for the antigen. 2 The decreased frequency of DW4 in JRA was an intriguing observation. Because it suggested that another HLA-D specificity might be increased, the typing experiments were extended to include the other known HLA-D specificities for which homozygous typing cells were available. The results showed increases in the antigens DW7, DW8, and TMo.
The classification of patients with juvenile arthritis, according to the pattern of disease during the initial 6 mo, appears to be a useful way of dividing these patients into clinical groups. It was interesting to observe that the lowest frequency of HLA-DW4 was in the children with a pauciarticular onset. It was also this group that most frequently had the antigens DW7, DW8, and TMo. The two observations are likely to be related. HLA-DW7 occurred also with a higher frequency in the systemic group, but because this result is based on the typing of only 14 patients, interpretation of its significance must await further studies.
The clinical classification we have used separated boys who began their disease after the age of 9 yr from the 67 children with a pauciarticular onset. This small group was strongly associated with HLA-B27. It has been observed that boys with late onset pauciarticular arthritis have many hallmarks of early ankylosing spondylitis (2) . Several of our patients in this group had sacroiliitis suggesting a similar relationship.
TMo is a JRA patient. The fact that she is homozygous for the HLA-D locus was first discovered in checkerboard cultures among random JRA patients and subsequently confirmed by family study. To genetically determined structures. To obtain the TMotyping response, some individuals would be required to possess, in addition to DW7 or DW11, or both, an extra determinant that characterizes TMo. In other persons TMo may exist alone and the determinants that characterize DW7 or DW1 1 are not detectable; this has thus far been observed only in JRA patients.
The presence of TMo was associated most strongly with the persistent pauciarticular form of arthritis. In this group, the frequency of the antigen TMo was 46%, compared to 1% in the normal controls. The relative risk was extremely high (67.7). Thus, it appears likely that the increased frequency of TMo in the pauciarticular onset group was largely because of its high frequency in patients with the persistent pauciarticular form of juvenile arthritis. Considering the imperfections of the clinical classification, it seems possible that almost all of the positive children belong in one group. The two patients who began their disease at an older age and the three children who developed a few more joints than the maximum of four used in the classification, may in reality belong to the same group. There were however some TMo-positive children in the systemic and the polyarticular onset groups. These patients will be followed to determine whether their course will differ from other patients with the same onset.
It is well known that the distribution of histocompatibility antigens varies greatly in subjects of different ethnic backgrounds. Care was therefore taken in the present study to limit the analysis to Caucasian patients living in and around the Dallas area. The two groups of patients with adult RA previously studied (3) were drawn from the same population. The difference in the HLA-D typing of adult and juvenile arthritis patients is therefore most likely because of a difference in the nature of the disease. The frequency of TMo in adult RA is currently being investigated. Preliminary results suggest that it may be somewhat higher than in normal controls, but the frequency is nothing like that of the pauciarticular group of JRA. Additional studies with typing cells for HLA-DW7 are also currently underway.
The mechanism of these and other HLA and disease associations is presently unknown. One possibility to be considered in RA, is that histocompatibility-linked control of the immune response may be involved. Such an effect could be exerted through specific immuneresponse genes, or it could be mediated through histocompatibility-linked control of cellular interactions between lymphocytes of different subsets or between lymphocytes and macrophages (12 
